2009
DOI: 10.5694/j.1326-5377.2009.tb02822.x
|View full text |Cite
|
Sign up to set email alerts
|

Early use of high‐dose insulin euglycaemic therapy for verapamil toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
53
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(53 citation statements)
references
References 13 publications
0
53
0
Order By: Relevance
“…Intravenous calcium infusion is logically indicated to overcome intracellular hypocalcemia but the benefit in overdose is unclear and may even be toxic [10]. Hyperinsulinemic euglycemia (HIE) therapy and glucagon administration have been suggested to improve cardiac inotropy and utilization of glucose, with some success [2,11-13]. However, all of these interventions act secondarily by supporting the body while the drug is naturally eliminated, as opposed to directly neutralizing the circulating drug.…”
Section: Introductionmentioning
confidence: 99%
“…Intravenous calcium infusion is logically indicated to overcome intracellular hypocalcemia but the benefit in overdose is unclear and may even be toxic [10]. Hyperinsulinemic euglycemia (HIE) therapy and glucagon administration have been suggested to improve cardiac inotropy and utilization of glucose, with some success [2,11-13]. However, all of these interventions act secondarily by supporting the body while the drug is naturally eliminated, as opposed to directly neutralizing the circulating drug.…”
Section: Introductionmentioning
confidence: 99%
“…Most authors have defined a clinical improvement in CCB and BB overdose cases as favorable changes in BP, MAP, HR, and/or mental status. Reported cases saw beneficial increases in these parameters within the range of 30 minutes to 4 hours from the commencement of HIET . Some authors have also noted improvements in slight EKG abnormalities within hours after beginning HIET .…”
Section: Discussion and Implications For Practicementioning
confidence: 92%
“…There does not appear to be any clear indication for when therapy should be discontinued, but the potential exists for patients to deteriorate into cardiac arrest upon premature discontinuation . There are several reports of patients stopping or being tapered off HIET who then experienced significant hypotension that resolved upon HIET reinitiation . Clinicians may have attempted to discontinue HIET in favor of agents they had more familiarity with or due to concern for possible adverse drug events.…”
Section: Discussion and Implications For Practicementioning
confidence: 99%
“…In human medicine, treatment with ILE and HDI are now recommended for initial therapy in treating CCB toxicosis . Although no prospective clinical trials are available to critically assess efficacy, there are multiple animal experimental models and human case reports that support these treatment interventions over previous traditional therapies (eg, glucagon, vasopressors) , , …”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that the insulin infusion could have been increased had the patient not responded clinically and treatment of future cases may consider HDI with doses as high as 10 U/kg/h . In the human literature, it is advocated to pursue ILE and HDI therapies early in cases with severe refractory CCB toxicosis , , . These treatments are relatively novel to veterinary medicine; therefore, initially conservative therapies (including the use of IV fluid therapy, calcium administration, glucagon, and dopamine) were administered.…”
Section: Discussionmentioning
confidence: 99%